BIO-TECHNE Corp — Director's Dealing 2018

Aug 9, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2018-08-07

Reporting Person: Hippel James (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-07	Common Stock	M	2398.00	$0.00	Acquired	5477.00	Direct
2018-08-07	Common Stock	F	1094.00	$180.14	Disposed	4382.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-07	Restricted Stock Units	$	M	2398.00	Disposed		Common Stock (2398.00)	Direct
2018-08-07	Restricted Stock Units	$	D	602.00	Disposed		Common Stock (602.00)	Direct
2018-08-07	Stock Options (Right to buy)	$108.49	D	3762.00	Disposed	2022-08-07	Common Stock (3762.00)	Direct
2018-08-08	Restricted Stock Units	$	A	3383.00	Acquired		Common Stock (3383.00)	Direct
2018-08-08	Stock Options (Right to buy)	$177.32	A	24089.00	Acquired	2025-08-08	Common Stock (24089.00)	Direct
2018-08-08	Stock Options (Right to buy)	$177.32	A	18066.00	Acquired	2025-08-08	Common Stock (18066.00)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$		Common Stock (4438.00)	4438.00	Direct
Restricted Stock Units	$		Common Stock (4925.00)	4925.00	Direct
Stock Option (Right to Buy)	$106.59	2023-08-18	Common Stock (30400.00)	30400.00	Direct
Stock Option (Right to Buy)	$94.35	2021-08-12	Common Stock (35000.00)	35000.00	Direct
Stock Option (Right to Buy)	$86.25	2021-04-01	Common Stock (10000.00)	10000.00	Direct
Stock Options (Right to buy)	$125.05	2024-08-09	Common Stock (24460.00)	24460.00	Direct
Stock Options (Right to buy)	$125.05	2024-08-09	Common Stock (32613.00)	32613.00	Direct
Stock Options (Right to buy)	$108.49	2022-08-07	Common Stock (25000.00)	25000.00	Direct
Stock Options (Right to buy)	$106.59	2023-08-18	Common Stock (40533.00)	40533.00	Direct
Stock Options (Right to buy)	$86.25	2021-04-01	Common Stock (25000.00)	25000.00	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: On 8/7/2018, the Board of Directors authorized discretionary vesting for 2,398 performance RSUs. The remainder of the performance RSUs were forfeited.

F3: On 8/7/2018, the Board of Directors authorized discretionary vesting for 14,988 performance options. The remainder of the performance options were forfeited.

F4: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F5: Vests 6,023 shares on 8/8/2019, 6,022 shares on each 8/8/2020, 8/8/2021, 8/8/2022

F6: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F7: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.

F8: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)

F9: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F10: 8,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.

F11: Fully exercisable

F12: Vests 8,153 shares each on 8/19/2018, 8/9/2019, 8/9/2020 and 8,154 on 8/9/2021

F13: 6,250 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.

F14: Vests 10,134 shares on 8/18/17, and 10,133 shares on each of 8/18/18, 8/18/19 and 8/18/20.